Background: Differences in behavioral phenotypes between the two most common subtypes of Prader-Willi syndrome (PWS) (chromosome 15q deletions and maternal uniparental disomy 15 (UPD) indicate that distinct neural networks may be affected. Though both subtypes display hyperphagia, the deletion subgroup shows reduced behavioral inhibition around food, whereas those with UPD are generally more able to maintain cognitive control over food intake impulses. Objective: To examine the neural basis of phenotypic differences to better understand relationships between genetic subtypes and behavioral outcomes. We predicted greater food motivation circuitry activity in the deletion subtype and greater activity in higher order cognitive regions in the UPD group, especially after eating. Design and participants: Nine individuals with PWS due to UPD and nine individuals with PWS due to (type 2) deletion, matched for age, gender and body mass index, underwent functional magnetic resonance imaging (fMRI) while viewing food images during two food motivation states: one before (pre-meal) and one after (post-meal) eating a standardized 500 kcal meal. Results: Both PWS subgroups showed greater activity in response to food pre-and post-meal compared with the healthy-weight group. Compared with UPD, the deletion subtype showed increased food motivation network activation both pre-and postmeal, especially in the medial prefrontal cortex (mPFC) and amygdala. In contrast, the UPD group showed greater activation than the deletion subtype post-meal in the dorsolateral prefrontal cortex (DLPFC) and parahippocampal gyrus (PHG). Conclusion: These preliminary findings are the first functional neuroimaging findings to support divergent neural mechanisms associated with behavioral phenotypes in genetic subtypes of PWS. Results are discussed within the framework of genetic mechanisms such as haploinsufficiency and gene dosage effects and their differential influence on deletion and UPD subtypes, respectively.
Introduction
Affecting one in 20 000 live births, 1 Prader-Willi syndrome (PWS) is a contiguous gene syndrome, which results from the lack of expression of several imprinted genes in the 15q11-q13 region from the paternal chromosome 15.
Phenotypic characteristics of PWS encompass physical (short stature, hypogonadism, narrow bifrontal diameter, obesity), behavioral (skin-picking, obsessive-compulsive behaviors, temper tantrums) and cognitive (intellectual delay, jigsaw puzzle ability) domains. 2, 3 However, the most striking features of PWS are hyperphagia and obesity. Although initially showing failure to thrive in infancy, around age 2 years, individuals with PWS begin displaying an insatiable appetite that, if left unchecked, leads to obesity by early to middle childhood. Behaviors associated with extreme overeating in PWS include food foraging and hoarding, theft of money to purchase food and consumption of non-food items. 4, 5 Zipf and Bernston 6 reported a mean consumption of over three times the normal caloric intake in individuals with PWS when they were allowed to consume sandwich quarters ad libitum. Consequences of unattended hyperphagia in PWS include maintenance of over 200% ideal body weight (in 1/3 of the PWS population) and occasional stomach rupture 7 (isolated cases reported). Treatment for hyperphagia and obesity in PWS requires a regimented diet and environmental control, which can be successful in preventing obesity. 5, 8, 9 Recent studies also document success in obesity prevention using growth hormone treatment. 10, 11 However, like diet and environmental control, growth hormone treatment does little to address hyperphagia in PWS.
In approximately 70% of individuals with PWS, the syndrome results from deletion of genetic material from the paternally donated chromosome number 15. The length of this deletion varies, such that two classes of individuals with the typical deletion have been identified: the longer type I deletion and the shorter type II deletion. 3, [12] [13] [14] [15] The majority of the remaining individuals with PWS (B25%) have maternal uniparental disomy (UPD), in which both copies of chromosome 15 are donated by the mother, with no paternal copy. The remaining B5% of individuals with PWS have atypical deletions, imprinting center defects or chromosome 15 translocations. Individuals with the deletion subtype are more likely to display hypopigmentation, lower weight at birth, high pain threshold and more 'typical' PWS-related facial features. 2, 16, 17 Behaviorally, individuals with deletion exhibit more severe problems than those with UPD, including mood swings and skin-picking behaviors, and a higher tendency to overeat and steal food. [18] [19] [20] Conversely, subtype comparisons characterize individuals with UPD as displaying higher verbal IQ scores, greater preference for routine, higher levels of psychosis and social impairments, lower daily living skill scores and poorer performance on tasks requiring discrimination of moving shapes. 16, 18, [21] [22] [23] [24] [25] One of the main goals of specification of PWS subtype phenotypes is to further delineate the function for genes involved in PWS. Currently, approximately 20 genes have been mapped to the B6-Mb PWS region, including SNRPN-SNURF, snoRNAs, IPW, NDN, MAGEL2, MKRN3, UBE3A, ATP10A, GABRB3, GABRA5, GABRG3, NIPA1 and NIPA2. 3 Genes involved in the PWS phenotype in general are maternally imprinted and paternally expressed, such that individuals with PWS either have no inherited copy of the paternally expressed genes (deletion subtype), or both maternal gene copies are imprinted and inactivated (UPD subtype), both resulting in the absence of functional paternal alleles for genes in this region.
However, subtle behavioral differences that exist between subtypes might arise from a variety of proposed genetic mechanisms. Haploinsufficiency of genes in the PWS region in the deletion subtype results in the reduced expression of non-imprinted genes in these individuals, a potential explanation for the characterization of a more severe phenotype in individuals with the typical deletion. Alternatively, individuals with PWS due to UPD inherit two copies of maternally expressed genes, resulting in a gene dosage effect with elevated expression of these genes. Furthermore, any imprinted genes distal to 15q11-q13 would be affected in individuals with UPD but not in individuals with a deletion. When the genes involved in these subtle genetic disruptions happen to be expressed in brain tissue, the results of the disruption might be seen in behavioral differences. Specifically, these mechanisms might lead to variation in the pattern of neural activation in response to stimuli that are salient to the PWS phenotype, including hyperphagia.
Given the effects of hyperphagia on health, family functioning and quality of life in the PWS population, delineation of its cause remains a critical research objective. Identification of the effect of gene dysregulation on brain development and function represents the overarching goal. Recent functional neuroimaging studies provide evidence for neural system dysfunction related to hyperphagia in PWS. In a functional magnetic resonance imaging (fMRI) study utilizing a temporal clustering approach, Shapira and colleagues 26 found delayed signal reduction in the hypothalamus, ventromedial prefrontal cortex, insula and nucleus accumbens following glucose administration in three individuals with PWS (subtypes not reported). Holsen and colleagues 27 studied nine individuals with PWS (7 deletion, 2 UPD) using fMRI and found greater activation in the PWS group compared with a matched healthy-weight group in response to food images after eating, suggesting a hyperresponsive neural network and disruption of reward circuitry relating to food motivation in PWS. Other recent findings provide additional support for reward circuitry dysregulation and a hyperresponsive neural network related to food processing in PWS. 28, 29 Additional reports of greater reward circuitry activation in response to foods of higher calorie content during hunger in individuals with PWS, compared with IQ-matched individuals, suggest that neural mechanisms of hyperphagia in PWS extend beyond a hyperresponsive neural network and, further, cannot be accounted for by differences in cognitive functioning level. 30 Three-factor eating questionnaire Eating behavior was measured using a modified version of the three-factor eating questionnaire (TFEQ). 34 The TFEQ assesses degree of dietary restriction ('How often are you (is your child) dieting in a conscious effort to control your (his/ her) weight?'), eating disinhibition ('Do you (Does your child) eat sensibly in front of others and splurge alone?') and hunger level ('How often do you (does your child) feel hungry?') in a questionnaire format. For the purposes of this study, only the 13 initial items on this questionnaire were used. These questions ask individuals to rate their behavior on a 4-point scale (with lower ratings indicating lower dietary restriction, lower eating disinhibition and lower hunger levels). For individuals with PWS, parents or guardians completed the TFEQ on behalf their child/ward. Individuals in the HWC group completed a self-report version of the TFEQ.
fMRI acquisition Scanning was performed on either a 3 Tesla Siemens Allegra or Trio scanner (Siemens, Erlangen, Germany) fitted with a quadrature head coil. Participants' heads were immobilized with head cushions. Most participants were scanned at the University of Kansas Medical Center (n ¼ 22; Allegra) with the remaining participants (all PWS) scanned at the University of Rochester Medical Center (URMC; Trio). One anatomical and two functional sequences were run in each scanning session (that is, pre-meal and post-meal). T1-weighted anatomical images were acquired using threedimensional ( We have calculated that one effect of a shorter TE (36 ms) is an increase in the signal-to-noise ratio (SNR) by B7% based on the typical T2* in cortical gray matter, 35 compared with the SNR at TE ¼ 40 ms. The other effect is a decrease of taskinduced BOLD signal change by B10% compared with that at TE ¼ 40 ms. As the fMRI contrast-to-noise ratio (CNR) is proportional to the product of SNR and BOLD signal changes, the change of the CNR at TE ¼ 36 ms is estimated at B3% reduction compared with that at TE ¼ 40ms. Therefore, it is expected that the overall effect of the TE difference is not significant and within the range of the experimental variations. Moreover, given the rarity of the population of individuals with PWS (especially individuals with UPD), we believe the compromise of slightly different acquisitions is justified.
Experimental paradigm
Participants viewed pictures of food, animals and Gaussianblurred low-level baseline control images during two scanning sessions; one after fasting for 4 h (pre-meal condition) and one immediately after eating a small uniform meal (post-meal condition) that was standardized for total number of calories (kcal ¼ 500), as well as macro-and micronutrient content. The order of sessions (pre-meal, post-meal) was counterbalanced across participants. All participants fasted for 4 h before eating in the pre-meal condition. In the post-meal condition, the meal was consumed outside the scanner and the scan begun within 15 min of completing the meal.
Activation paradigm
Visual stimuli of two categories (food and blurred baseline control images) were obtained from LaBar and colleagues. 36 Because of the mental and chronological age of some of the participants in this study, the comparison stimuli were animals to keep participants attentive to the task and to control for general familiarity. All images for the animal category were obtained from professional stock CD-ROMs and matched to food and blurred control images with respect to brightness, resolution and size. Each image was presented one time only to each participant during the fMRI scanning. Each functional scan involved three repetitions of each block for stimulus condition type (that is, food, animal), alternated between blocks of blurred images. Visual stimuli were projected through 3D limited view goggles (Resonance Technology Inc., Northridge, CA, USA) controlled by the stimuli-generating computer program (NeuroSTIM, Neuroscan, El Paso, TX, USA). Stimulus presentation time was 2.5 s, with an interstimulus interval (ISI) of 0.5 s. Within each of the two functional scans there were 13 blocks of stimulus presentation; within each block, 10 images were presented. The order of category presentation was counterbalanced across participants.
To ensure that participants were attending to the stimuli being presented, they were instructed to remember images for a memory test following the scanning session. From each of the food and animal groups, approximately 50% of the images used in the scanning session were chosen for recall and interspersed with novel distracter images from the same category. Participants completed a recognition memory test outside the scanner, immediately following each scanning session. Participants were instructed to press one key if they had seen the image in the scanner (old) and another key if they had not seen the image (new).
fMRI data analysis Functional magnetic resonance imaging data were analyzed using the BrainVoyager QX statistical package (version 1.8; Brain Innovation, Maastricht, the Netherlands). Preprocessing steps included trilinear 3D motion correction, sincinterpolated slice scan time correction, 3D spatial smoothing with a 4-mm Gaussian filter, and high pass filter temporal smoothing. Functional images were realigned to the anatomic images obtained within each session and normalized to the BrainVoyager template image, which conforms to the space defined by Talairach and Tournoux's stereotaxic atlas. 37 Motion in any run of more than 4 mm along any axis (x, y or z) resulted in the discard of that run. In addition, behavioral evidence of diminished attention due to excessive sleepiness resulted in discard of that run. From each group, runs that met these criteria were discarded (DEL: 4 runs; UPD: 10 runs; HWC: 0 runs). Activation maps were analyzed using statistical parametric methods 38 as implemented in the BrainVoyager QX software. Statistical contrasts were conducted using multiple regression analysis with the general linear model, allowing for multiple predictors to be built into the model. Regressors representing the experimental conditions of interest were modeled with a hemodynamic response filter and entered into the multiple-regression analysis using a fixed-effects model. Contrasts between conditions of interest were assessed with t-statistics. Statistical parametric maps were overlaid on a 3D anatomical volume created by averaging T1 structural scans across all subjects. Analysis began with between-group comparisons (DEL vs HWC, UPD vs HWC) of response to food vs baseline images separately within each session (pre-and post-meal). These analyses were carried out to determine whether each PWS genetic group showed activation patterns that were different from the healthy-weight group and to replicate our earlierreported findings comparing a group of individuals with Table 2 and Figure 1 ). The UPD group showed a stronger BOLD response to food images pre-meal compared with the DEL group in the PHG and FG, in the MFG and CING, and in several temporal lobe and posterior regions, including the ITG, SPL, angular gyrus, paracentral lobule, precuneus and middle OG.
DEL vs UPD: post-meal response.
Comparison of DEL and UPD groups post-meal indicated greater activation in the DEL group in the mPFC, and several additional frontal regions, including the MFG, SFG and CING (see Table 3 and Figure 2 ). Individuals in the UPD group, conversely, exhibited greater activation post-meal in a contrasting set of food motivation areas, including the DLPFC, PHG and FG. In addition, the UPD4DEL contrast yielded activation in the IFG and SFG, and in several motor, temporal and posterior regions, including the PreC, PostC, MTG, STG, IPL and SMG.
Discussion
Recent reports identifying genetic markers in the 15q11-q13 region have allowed for more detailed delineation of genebrain behavior relationships in this syndrome. 3, 40, 41 In this exploratory study, we capitalized on those findings and recent advances in neuroimaging tools to examine possible variation between genetic subtypes of PWS in brain activation patterns linked to hyperphagia, the most striking phenotypic behavior associated with PWS. To our knowledge, this is the first report to examine subtype differences in brain activation in the PWS population. Current findings, though preliminary, suggest divergent patterns of neural activity in response to food images in DEL and UPD groups. Overall, individuals in the DEL group showed greater and more widespread brain activation to food images compared with the UPD group, both before and after eating. Further, consistent with our earlier findings in a mixed-subtype Genetic subtype differences in Prader-Willi syndrome LM Holsen et al group of individuals with PWS, we report striking differences between each genetic subtype group and the matched healthy-weight control group in their brain response to food stimuli before and after eating. Based on behavioral studies documenting poor behavioral inhibition (especially in situations involving food) amongst PWS individuals with the deletion subtype, we expected greater activation in this group compared with the UPD group in frontal and limbic regions associated with food motivation. In support of this hypothesis, the DEL group showed a more robust response than the UPD group pre-meal in several food processing regions associated with reward and affect-driven motivation, including the mPFC, insula and amygdala, and in widespread frontal regions including the IFG, MFG and SFG. Post-meal, the DEL group exhibited greater activity than the UPD group in the mPFC. Overall, these regions are similar to those we found for differences in the comparison between a mixed-subtype PWS group compared with a healthy-weight control group. 27 Further, this circuitry has previously been shown to respond to food-related stimuli in the hungry state in individuals with healthy weight and is associated with emotional and food-related processing.
36,39
The mPFC is associated with integration of visceral and reward-based signaling, and is consistently reported to show greater activation in obese individuals after eating. 42, 43 The mPFC is closely connected to the OFC, which is involved in stimulus reward evaluation in concert with direct multisensory input. 44 With these inputs and reciprocal connections to the hypothalamus, the mPFC is uniquely situated to process visceromotor signals. 45 Earlier reports on neural mechanisms of hyperphagia have noted strong mPFC activation in individuals with PWS, most of whom had the deletion subtype. [27] [28] [29] [30] Interestingly, Hinton and colleagues 46 reported a lack of association between activation in the mPFC and ratings of the reward value of various foods in a group of PWS individuals with deletion, suggesting that although these individuals do not have higher ratings on food desirability compared with control groups, they display hyperactivity in regions associated with behavioral disinhibition and lack of self-control. We propose that higher levels of activation in the DEL group, especially in the mPFC, might be associated with the behavioral observation of a higher level of preoccupation with food in this group. Consistent with our predictions, individuals with UPD showed stronger brain activation post-meal in food processing regions associated with higher cognition, including the DLPFC, and PHG. The lateral PFC maintains direct connections with sensory and nearby motor networks, and is indirectly connected to the limbic regions, well situating it for a role in integration of sensory cues, reward signals and voluntary motor control. 47 Top-down processing in the lateral PFC allows regions such as the DLPFC to influence processing in other regions to obtain a common goal. This role in cognitive control might extend to decision-making related to food intake, as suggested by findings of increased DLPFC activity during satiation in a group of successful dieters. 48 For PWS individuals with UPD, this might imply a more intact ability to recruit the DLPFC after eating, which allows for the influence of decision-making process in response to viewing foods that, although highly reinforcing (a reward-based response), would not be beneficial to their long-term health (a cognitive judgment). This evidence of more intact cognitive processing might be related to higher verbal IQ levels in this subtype group.
22
The DLPFC is also involved in working memory, including holding reward value in mind while judging potential outcomes of a given set of behavioral responses. 47 In light of the finding of a greater BOLD response in the PHG in individuals with UPD, this suggests that cognitive processes involved in food processing in individuals with UPD relate to memory functioning, despite the fact that behavioral results Genetic subtype differences in Prader-Willi syndrome LM Holsen et al failed to reveal a significant difference between UPD and DEL groups in memory task performance. Finally, PWS individuals with UPD showed greater activity in posterior regions involved in visual processing, suggesting a neural basis for differential visual processing in those with UPD, which has been reported earlier. 21 Paternally biased genes are susceptible to haploinsufficiency in the deletion subtype of PWS. The GABA-A receptor subunit gene GABRB3 has higher levels of expression in lymphoblastoid and frontal cortical brain tissue in individuals with UPD compared with the deletion subtype. 41, 49 Lucignani and colleagues 32 showed reduced GABA-A receptor binding in food-motivation areas using positron emission tomography in individuals with the deletion subtype. GABRB3, which codes for the GABA-A b3 receptor subunit, is preferentially expressed in the hypothalamus. 50 The GABRB3 knockout mouse has a striking neurological phenotype, displaying hyperactivity and learning and memory deficits, accompanied by findings of decreased benzodiazepine binding in the cortex, hippocampus, striatum and thalamus. 51, 52 This suggests that the GABRB3 gene might be involved in the behavioral phenotype of PWS, especially the deletion subtype. Paternally expressed genes include NDN, MAGEL2 and SNRPN-SNURF. Expressed in murine hypothalamus, OFC and anterior cingulate cortex, NDN is a neuronal cell regulator that acts to attenuate apoptosis of postmitotic neurons 53 and promotes differentiation of GABAergic neurons in the mouse forebrain. 54, 55 Cytoarchitecture in the developing brain is heavily influenced by the presence of NDN, as implied through abnormal neural cell migration and irregular axonal tract projection in the NDN knockout mouse. 56 The NDN knockout mouse exhibits decreased oxytocin-producing cells in the paraventricular nucleus of the hypothalamus. 57 MAGEL2 is also highly expressed in the murine hypothalamus and has been shown to be preferentially expressed in the SCN and SON of the hypothalamus, suggesting that it might be a marker for hypothalamic secretory neuron development. 55 The MAGEL2 gene knockout mouse has an increased vulnerability to obesity, increased fat deposition in abdomen, decreased lean muscle mass, abnormal circadian pattern of food intake. 58 The SNRPN-SNURF gene, highly expressed in the hypothalamus, OFC and ACC of the murine brain, 55 is involved in mRNA splicing in the brain and appears to aid in the regulation of imprinting in the PWS region of chromosome 15. Overall, these findings converge to suggest unique roles for NDN, MAGEL2 and SNRPN-SNURF in influencing development of behavior, which might influence food motivation regions in the brain. As opposed to haploinsufficiency mechanisms, maternally expressed genes such as UBE3A might be subject to gene dosage effects in PWS individuals with UPD. In the UPD subtype compared with the deletion subtype, this gene shows elevated expression in human lymphoblasts. 41, 49 UBE3A is expressed in human frontal cortical tissue, 41 with its expression showing increased specificity in certain brain regions over the course of development. 59 UBE3A expression is high in the developing hypothalamus, but not in mature adult hypothalamic tissue. Further, studies have shown that the maternal allele is necessary for expression of UBE3A in hippocampal and cerebellar Purkinje cells. 59 Joseph and colleagues 60 reported relative sparing of visual recognition skills in individuals with UPD, implying a beneficial effect of overexpression of UBE3A (that is, a gene dosage effect) on learning and memory processes in this subtype. These findings fit well with our current results of greater UPD activation in memory-related regions.
Although this study provides initial evidence of differences between UPD and deletion subtypes in patterns of neural activity associated with food motivation, a number of Genetic subtype differences in Prader-Willi syndrome LM Holsen et al methodological challenges limit the generalizability of these preliminary findings. Despite best efforts, including nationwide recruitment, we utilized relatively small sample sizes, a fixed-effects analytic approach and lack of correction for multiple comparisons, which might have decreased the power available to detect group differences and which prevent extrapolation to the PWS population as a whole. Several factors contributed to this issue, including rarity of the disorder, difficulty in finding eligible and compliant individuals, and limited ability to use all data due to the participant's movement and tendency to fall asleep during scanning, a result of excessive daytime sleepiness common in PWS. In addition, we were only able to recruit a small number of individuals with deletion type I. This subtype is less common, and individuals with deletion type I exhibited increased behavioral problems, leading to incomplete scanning sessions for those who were recruited. Further, although our groups were matched on age, we used individuals from a wide age range (10-48 years), which might have introduced age-related variation in brain structure and physiology to our combined sample. Although sampling from such a wide age range was inevitable given the rarity of the disorder, future investigations should attempt to utilize narrower age ranges. Several of our participants with PWS were also taking psychoactive medications, which might have altered neural responses to the stimuli. Psychotropic medications are commonly prescribed in the PWS population, (47% of individuals with deletion and 74% of individuals with UPD) even for those without psychopathology. 61 These high rates of medication use make it difficult to recruit medication-free participants. Future neuroimaging studies on PWS should attempt to include as many medication-free individuals as possible to reduce possible confounds. Finally, we combined data that was acquired under slightly different imaging parameters; namely a difference in TE (36 vs 40 ms). However, as detailed in the methods section, the potential consequence of this difference on our between-group findings was estimated at a B3% difference in the contrast-to-noise ratio, suggesting an Genetic subtype differences in Prader-Willi syndrome LM Holsen et al overall negligible effect not greater than the expected experimental variation. In summary, we report greater activity, in response to food stimuli before and after eating, across the food motivation network in PWS individuals with the typical deletion (specifically type II subtype), compared to those with UPD, especially in the mPFC and amygdala, regions involved in emotional processing and visceromotor integration. The UPD group also showed more activity in the DLPFC and PHG than the DEL group after eating, suggesting greater utilization of regions associated with cognitive control and memory. These unique patterns of activation match closely with behavioral evidence of decreased inhibition in the deletion subtype and greater restraint in the UPD group in situations involving food. These findings provide preliminary evidence for distinct gene-brain behavior relationships in subtypes of PWS and suggest potential avenues for exploration of specific gene functions, especially for maternally imprinted or paternally expressed genes in the 15q11-q13 region.
